ClinicalTrialsFinder
RecruitingNCT07619872

KONECT RESILIA Aortic Valved Conduit (AVC) Real-world Study Assessing Safety and Performance

Sponsor

Edwards Lifesciences

Enrollment

250 participants

Start Date

Jun 25, 2026

Study Type

OBSERVATIONAL

Conditions

Aortic Valve Disease

Summary

KONECTION is a prospective, observational, single-arm, multicenter study designed to collect real-world clinical outcomes in up to 250 participants who will receive the KONECT RESILIA aortic valved conduit, Model 11060A.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Edwards KONECT RESILIA AVC for people with aortic valve disease. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEEdwards KONECT RESILIA AVC

Surgical replacement of the aortic valve and ascending aorta with the Edwards KONECT RESILIA AVC

Locations(1)

TUM Klinikum Deutsches Herzzentrum

München, Bavaria, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07619872

Related Trials

CAPTURE-2: Controlled Arterial Protection to Ultimately Remove Embolic Material

NCT072767113 locations

Real World Data Collection on the INSPIRIS RESILIA Aortic Valve

NCT0712004814 locations

Aortopathy Relationship To Imagery and Kinocardiography Features (ARTIK)

NCT062863581 location

Prospective Long-Term Outcomes of a Standardized Ross Procedure

NCT063526711 location

Valved Graft PMCF Study

NCT0475421725 locations